Research Platforms
In November 2023, the "Zhejiang Engineering Research Center for Interventional Medicine Engineering and Biotechnology," led by Ji Jiansong, Secretary of the Party Committee of Lishui Central Hospital, received official approval. This marks the first provincial-level engineering research center within the city’s healthcare system and the second provincial-level scientific and technological innovation platform granted to Lishui Central Hospital—following the approval of the Zhejiang Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research. This milestone signifies the successful establishment of a comprehensive medical science and technology innovation system at the hospital, encompassing both basic and translational research. It holds substantial significance for advancing the city's healthcare services and promoting the development of the life and health industries.
The construction of the Zhejiang Provincial Engineering Research Center is designed to meet the urgent needs of key industries in the province. It focuses on breaking through core technological challenges and addressing critical "bottleneck" issues. With a mission to resolve major challenges in interventional medicine engineering and biotechnology—particularly those related to tumors and vascular diseases—the center is committed to promoting the industrialization and translational application of interventional medical devices and technologies. It also aims to drive the development of the entire industrial chain, both upstream and downstream, in the field of interventional medicine engineering. Ultimately, the center aspires to become a leading national hub for interventional medical research, thereby better serving the healthcare needs of the population.
Looking ahead, Lishui Central Hospital will continue to integrate resources and harness the collective strength of industry, academia, research, and clinical medicine. Efforts will be made to further refine and implement relevant policies and strategies, tackle clinical challenges directly, and consolidate research and development capabilities. The hospital is committed to achieving breakthroughs in key technological innovations, clinical research, and translational applications. In parallel, it will focus on cultivating a cohort of highly skilled professionals in both clinical and basic research related to interventional medical engineering. These efforts will support the high-quality development of Lishui’s healthcare sector and provide robust momentum and foundational support for building a model mountainous region characterized by shared prosperity and well-being.

